Studies related to Liver Enzymes and Bulbine natalensis

Short term safety of bulbine natalensis supplementation in healthy men
Effect Increase
Trial Design cohort
Trial Length 24weeks
Number of Subjects 36
Sex m
Notes for this study:
Following 28 days supplementation with 750mg bulbine natalensis noted a small (2%) but statistically significant increase in the liver enzyme ALP which was deemed to be clinically irrelevant. (Note: Double blind protocol said to have been used, but full text with methodology not available; currently a poster presentation)
Funding issues for this study:
Funded by Sports Nutrition Research, the producer of the tested supplement (ProLensis)